Aurora Cannabis: Why I Like This Stock
Aurora Cannabis Inc. outlook: improving international revenue, margins, and net cash. Valuation suggests 64% upside to $5.58. Click for more on ACB stock.
The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling FDA-approved and state-licensed medical cannabis products as a less harmful substance — a move that led to celebration but also confusion among industry...
Cannabis Stocks Soared—Than Sank. Here’s What Investors Need to Know.
Cannabis stocks and funds that hold them surged after the Trump administration moved it from the government most restrictive drug category to one that can be obtainable with a prescription.
Cannabis Stocks Jump After U.S. Reclassifies Marijuana as Less Dangerous Drug
Shares of cannabis companies rose after the Trump administration reclassified marijuana as a less dangerous drug. Curaleaf increased 5.8% in premarket trading after surging 26% Wednesday on a report …
Tilray and other pot stocks soar as Trump is reportedly ready to reclassify cannabis
The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Aurora Cannabis: Why I Like This Stock
Aurora Cannabis Inc. outlook: improving international revenue, margins, and net cash. Valuation suggests 64% upside to $5.58. Click for more on ACB stock.
The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling FDA-approved and state-licensed medical cannabis products as a less harmful substance — a move that led to celebration but also confusion among industry...
Cannabis Stocks Soared—Than Sank. Here’s What Investors Need to Know.
Cannabis stocks and funds that hold them surged after the Trump administration moved it from the government most restrictive drug category to one that can be obtainable with a prescription.
Cannabis Stocks Jump After U.S. Reclassifies Marijuana as Less Dangerous Drug
Shares of cannabis companies rose after the Trump administration reclassified marijuana as a less dangerous drug. Curaleaf increased 5.8% in premarket trading after surging 26% Wednesday on a report …
US set to move to reclassify marijuana as early as Wednesday, Axios reports
WASHINGTON, April 22 (Reuters) – The United States administration is expected to move to reclassify marijuana as soon as Wednesday, Axios reported, citing an official familiar with the matter, sending U.S. stocks of cannabis-related companies higher.
Tilray stock pops on new Trump-driven cannabis hopes. Should you chase the rally?
Tilray Brands (TLRY) stock closed meaningfully higher on Monday after President Donald Trump urged the DOJ, during an Oval Office event, to expeditiously reclassify cannabis as a Schedule III drug. As …
4 Red Flags Every Cannabis Investor Should Spot
Cannabis stocks can hide serious risks, from weak finances to regulatory threats, and spotting these red flags early can help investors avoid costly mistakes.
Is Aurora Cannabis (ACB) One of Best Tobacco and Cigarette Stocks to Look at
Aurora Cannabis Inc. (NASDAQ:ACB) is one of the 10 best tobacco and cigarette stocks to invest in. As of April 15 closing, broader consensus sentiment around Aurora Cannabis Inc. (NASDAQ:ACB) was …
SNDL Inc. (SNDL) is One Cannabis Stock Investors Should Not Ignore
As of April 15 closing, consensus sentiment around SNDL Inc. (NASDAQ:SNDL) was moderately bullish. The stock received 2 Buy ratings and carries a median 1-year target price of $4.75.
Recent Comments